BioRestorative Therapies (BRTX) Enterprise Value (2016 - 2025)
Historic Enterprise Value for BioRestorative Therapies (BRTX) over the last 14 years, with Q3 2025 value amounting to -$7.8 million.
- BioRestorative Therapies' Enterprise Value rose 4059.56% to -$7.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.8 million, marking a year-over-year increase of 4059.56%. This contributed to the annual value of -$20.4 million for FY2024, which is 8407.2% down from last year.
- Latest data reveals that BioRestorative Therapies reported Enterprise Value of -$7.8 million as of Q3 2025, which was up 4059.56% from -$11.7 million recorded in Q2 2025.
- In the past 5 years, BioRestorative Therapies' Enterprise Value registered a high of -$1.1 million during Q3 2021, and its lowest value of -$30.5 million during Q1 2024.
- Moreover, its 5-year median value for Enterprise Value was -$14.7 million (2022), whereas its average is -$14.9 million.
- Its Enterprise Value has fluctuated over the past 5 years, first crashed by 5222027.2% in 2021, then skyrocketed by 7014.35% in 2025.
- BioRestorative Therapies' Enterprise Value (Quarter) stood at -$1.1 million in 2021, then plummeted by 1205.59% to -$14.7 million in 2022, then increased by 24.97% to -$11.1 million in 2023, then tumbled by 84.07% to -$20.4 million in 2024, then skyrocketed by 61.83% to -$7.8 million in 2025.
- Its Enterprise Value was -$7.8 million in Q3 2025, compared to -$11.7 million in Q2 2025 and -$9.1 million in Q1 2025.